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Oxidative stress is deﬁned as an imbalance between pro-oxidants and antioxidants in favor of pro-oxidants. Photon
emission (also called chemiluminescence) has been widely used to study oxidative stress in biological systems
in vitro. In vivo chemiluminescence has been proposed as a non-invasive method to assess oxidative stress in the
skin. UVA (320–400 nm part of the ultraviolet radiation) exposure is generally accepted as a source of oxidative
stress in the skin. In this study, UVA-induced oxidative stress was studied by using an in vivo chemiluminescence
detection method. First, the dose response and the ﬂuence rate response of the UVA-induced oxidative stress in
human skin were investigated by examining the decay kinetics of the chemiluminescence signal following UVA
exposure. A kinetic model was proposed to help differentiate these two responses. We found that the initial burst of
the chemiluminescence signal depended on the UVA ﬂuence rate, whereas the decay of the signal following
exposure can be related to the UVA dose involved. Second, a signiﬁcant reduction of UVA-induced
chemiluminescence signal was observed after tape-stripping, indicating that stratum corneum is a major source
of UVA-induced oxidative stress in the skin. Furthermore, the oxygen dependence of UVA-induced chemilumines-
cence signal was also conﬁrmed by application of a pressure cuff, implying that some of the oxidative stress
occurs in the deeper layers of the skin. Finally, topical application of vitamin C before exposure signiﬁcantly
reduced the UVA-induced chemiluminescence signal. We thus conclude that chemiluminescence is an effective
method to assess the oxidative stress induced by UVA in human skin in vivo.
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Ultraviolet radiation is an external stressor to the skin and
can induce a number of reactions. UVB radiation is believed
to interact directly with molecular species in the epidermis
and dermis to produce alterations in biological structures and
processes. UVA (320–400 nm part of the ultraviolet radiation),
on the other hand, is believed to act through the generation
of reactive oxygen/nitrogen species (free radicals), which
then interact with various molecular species such as nucleic
acids, proteins, and lipids (Krutmann, 2000). Previous studies
have shown that depletion of either skin surface oxygen
supply or blood oxygen supply to the skin may reduce the
UVA-induced pigmentation (Gange, 1988), indicating the
importance of oxygen in UVA-induced skin reactions.
Oxidative stress is a phenomenon closely associated
with life. Even under normal circumstances, most biological
processes include the generation of free radicals with
simultaneous photon emission. The number of emitted
photons, however, is insufficient to be detected with current
instrumentation. Pro-oxidants continuously produced in the
skin under normal conditions can be easily accommodated
by the endogenous antioxidant systems. Noxious agents,
such as UVA, peroxides, and hypochlorite, can generate
oxidative stress at a rate exceeding the rate of constitutive
antioxidant regeneration, thereby leading to an elevated
level of reactive species in the skin. The reaction between
this excess and skin constituents results in the emission of
photons with low quantum efficiency but detectable with
current methods (Evelson et al, 1997; Sauermann et al,
1999; Stab et al, 2000; Yasui and Sakurai, 2000). Photon
emission in the visible wavelength range has been
associated with reactive oxygen species (Boveris et al,
1980, 1981; Evelson et al, 1997).
In this study, we have applied chemiluminescence to
investigate UVA-induced oxidative stress in human skin
in vivo by asking: (a) How does the skin recover from the
UVA-induced oxidative stress? Chemiluminescence signals
undergo a fast decay immediately following UVA exposure.
A detailed study of the decay kinetics may provide an
insight into the interaction between UVA photons and the
skin and how the skin antioxidant system responds to UVA.
(b) As UVA penetrates well into the dermis, where do the
oxidative reactions occur in the skin during and following
UVA exposure? It has been suspected that the stratum
corneum as well as the viable epidermis and dermis may
contribute to the detected photons (Sauermann et al, 1999;
Tian et al, 2001). (c) If the in vivo chemiluminescence is
directly related to oxidative stress in the skin, how does the
change in the oxygen supply to the skin affect the signal?
Abbreviation: ESR, electron spin resonance; UVA, 320–400 nm part
of the ultraviolet radiation
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More importantly, does topical application of antioxidants
reduce the UVA-induced skin chemiluminescence?
Results
Chemiluminescence could be used to evaluate oxidative
stress in human skin in vivo and UVA-induced skin
chemiluminescence signal decays exponentially with
time The spontaneous photon emission from normal skin is
very weak (Fig 1a–c). The chemiluminescence signal is only
20–40 counts per second higher than the instrument
background level (Fig 1a). Both UVA exposure and topical
application of oxidizing chemical agents induce oxidative
stress in the skin. As shown in Fig 1a–c, the in vivo
chemiluminescence signals were significantly elevated
when the skin is exposed to UVA or low concentrations of
hydrogen peroxide (Fig 1b) and sodium hypochlorite
solutions (Fig 1c). For UVA, the signal starts from its
maximum value immediately following the exposure (2 J
per cm2 delivered at 20 mW per cm2) and then undergoes a
rapid decay to reach its original level in a few minutes. The
data can be fitted to a two-parameter exponential decay
function with R240.95.
Rate of chemiluminescence decay decreases with
increasing UVA doses UVA dose responses on the
chemiluminescence signal were studied to better under-
Figure 1
Both UVA exposure and topical application of oxidizing
chemical agents induce skin chemiluminescence (repre-
sentative data). (a) Spontaneous and UVA (2 J per cm2 at 20
mW per cm2)-induced chemiluminescence signals (black
circles) from a subject of Fitzpatrick skin type III were collected
as a function of time. The instrument background is repre-
sented with open circles. (b) Comparison of spontaneous and
hydrogen peroxide (120 mg per cm2)-induced chemilumines-
cence signals from the skin. The interval between the two
measurements corresponds to the application time. (c)
Comparison of spontaneous and sodium hypochlorite (0.1 mg
per cm2)-induced chemiluminescence signals from the skin.
The interval between the two measurements corresponds to
the application time.
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stand the decay kinetics. The UVA doses ranging from 0.2 J
per cm2 to 10 J per cm2 were all delivered to the skin with a
fluence rate of 20 mW per cm2. It is obvious that the skin
recovers differently with different doses (Fig 2a). The total
counts of the first 300 sec of chemiluminescence signal
showed a monotonic increase with the dose (Fig 2b). The
dose response tends to reach a plateau between 2 and 5 J
per cm2. All the curves were fitted to an exponential decay
function and their decay constants (parameter ‘‘B’’) were
calculated and averaged for all the nine subjects. As a
general trend, chemiluminescence signals decayed more
slowly with higher UVA doses (Fig 2c). The decay rate tends
to drop very fast from 0.5 to 2 J per cm2, and this change of
decay rate slows down after 2 J per cm2. The data in Fig 2c
can be fitted to an equation y¼ 0.82þ1.64  e0.79x with
R2¼ 0.96. We also found that the initial burst of the decay
(parameter ‘‘A’’) does not correlate significantly with the
dose and varies from person to person.
Initial chemiluminescence signal from the skin in-
creases with UVA ﬂuence rate Chemiluminescence de-
cay curves with different UVA fluence rates were measured
Figure2
Rate of chemiluminescence decay decreases with increas-
ing UVA doses. (a) UVA-induced chemiluminescence decay
curves of different UVA doses (ranging from 0.2 to 10 J per cm2)
at the same fluence rate (20 mW per cm2). The data from one
representative subject are shown. (b) The data were integrated
for the first 300 s for each curve. The integrated signals
(Mean  SD, N¼9 subjects) are plotted as a function of UVA
dose. (c) UVA dose response of the decay constant
(Mean  SD, N¼ nine subjects).
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(Fig 3a). The UVA dose used in this set of experiments was
fixed at 2 J per cm2, with fluence rates ranging from 2 to
20 mW per cm2. The total counts of the first 300 s of the
chemiluminescence signal as a function of the fluence rate
also exhibit a monotonic increase (Fig 3b). The initial burst
of the decay (parameter ‘‘A’’) is dependent on the fluence
rate (Fig 3c). A quadratic relation (y¼ 15.8þ34.9x0.8x2
with R2¼0.98) can be found between the fluence rate and
the initial burst of the chemiluminescence signals. The
decay constant (parameter ‘‘B’’) for the same UVA dose (2 J
per cm2) is about 0.01 per s and is independent of the
fluence rate.
UVA-induced skin chemiluminescence originates in part
in the stratum corneum Tape-stripping is a widely used
method to remove the superficial layers of the stratum
corneum. To determine how much skin was removed, we
applied confocal microscopy to monitor the thickness of the
stratum corneum before and after 10 tape-strips. The result
showed a change of 3.5  1.7 mm, indicating that only part
Figure 3
Initial chemiluminescence signal from the skin increases
with UVA fluence rate. (a) UVA-induced chemiluminescence
decay curves of different UVA fluence rates (ranging from 2 mW
per cm2 to 20 mW per cm2) at the same dose (2 J per cm2). The
data from one representative subject are shown. (b) The data
were integrated for the first 300 s for each curve. The integrated
signals (Mean  SD, N¼9 subjects) are plotted as a function
of UVA fluence rate. (c) UVA fluence rate response of the initial
burst (Mean  SD, N¼ nine subjects).
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of the stratum corneum had been removed. Increasing the
number of tape-strips may remove more layers, but it may
also induce an inflammatory response (erythema). Indeed,
in this study, 10 tape-strips did not generate any visible or
measurable skin inflammatory response. Comparison of the
initial burst of the decay curves for the same skin site before
and after 10 tape-strips (Fig 4a and b) reveals that about
30% of the chemiluminescence signal came from the
outermost layers of the stratum corneum.
UVA-induced skin chemiluminescence is oxygen de-
pendent Oxygen in skin tissue can be supplied via diffusion
from the surface of the skin or via the blood circulation
(Stucker et al, 2002). Applying a pressure cuff on the upper
arm can regulate the oxygen supply to the tested skin sites.
Previous studies have shown that blood oxygen supply
plays an important role in UVA-induced erythema and
pigmentation (Gange, 1988). Here, we found that increasing
the occlusion pressure (with a pressure cuff) results in a
decrease in the chemiluminescence signal (up to 40% for
60 mmHg) following UVA exposure (Fig 5a). The portion of
the chemiluminescence signal affected by the blood oxygen
supply is probably from the deeper layers of the skin, since
outermost layers of the skin are still supplied with atmo-
spheric oxygen during the UVA exposure. Furthermore, in a
separate experiment, tape-stripping was combined with the
application of a pressure cuff. This combination resulted in a
greater reduction of the UVA-induced chemiluminescence
signal than either tape-stripping or pressure cuff alone (Fig
5b). Together, these results confirm that UVA induces an
oxidative stress in both the stratum corneum and viable skin
layers.
Topical application of vitamin C can reduce the UVA-
induced skin chemiluminescence To further determine
the direct relationship between oxidative stress in skin and
chemiluminescence measurements, vitamin C, a known
antioxidant was applied on the skin 4 hrs prior to UVA
exposure. Vitamin C does not absorb in the UVA wavelength
range (data not shown) and consequently has no UVA-
filtering effect. The significant reduction in the chemilumi-
nescence signal by vitamin C (Fig 6) confirms the
occurrence of reactive oxygen intermediates in the skin
induced by UVA exposure.
Discussion
It has been established that UVA exposure can induce
reactive intermediate species, which can further react with
nucleic acids, lipids, and proteins in the skin (Krutman,
2000). Electron spin resonance (ESR) studies have shown
that lipid alkyl and alkoxyl radicals can be generated in skin
biopsies following UVA exposure (Jurkiewicz and Buettner,
1996; Herrling et al, 2002). From a different aspect, Packer
and coworkers have shown that the cutaneous antioxidant
defense system can be impaired by UVA irradiation (Fuchs
et al, 1989; Thiele et al, 1999). These studies strongly
support the argument that UVA induces oxidative stress in
human skin (Klein-Szanto and Slaga, 1982; Panasenko,
1997; Thiele et al, 1999).
Chemiluminescence is a widely accepted method to
study oxidative reactions in cells and in whole organs
(Boveris et al, 1980, 1981). Using a similar instrument, we
have investigated the oxidative stress in human skin in vivo.
We have focused on the measurement of UVA-induced
Figure 4
UVA-induced skin chemiluminescence originates in part in the
stratum corneum. (a) UVA-induced chemiluminescence decay curves
before and after 10 tape-strips (UVA dose¼ 2 J per cm2 and fluence
rate¼15 mW per cm2). Representative data from one subject are
shown. (b) Initial burst of chemiluminescence (Mean  SD, N¼ 5
subjects) for the skin site before and after 10 tape-strips. p value was
calculated from paired t test.
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oxidative stress in this study, but the same method can also
be used to monitor the oxidative stress induced by other
oxidizing agents. In this study, we have shown that the
emission of chemiluminescence increases with the applica-
tion of known oxidative agents (peroxides and chlorine) in
Fig 1b and c. Therefore, the observed difference between
spontaneous chemiluminescence and UVA-induced chemi-
luminescence (Fig 1a) may be related directly to the skin
oxidative stress.
A major advantage of the in vivo chemiluminescence
measurement method is that it is non-invasive. ESR that has
the potential of identifying the reactive intermediates in the
skin in vivo (He et al, 2002). In vivo measurement of reactive
intermediates in the skin by ESR, however, requires topical
application of spin-traps. Tape-stripping and subsequent
chemical analysis of the skin tissues on the tape have also
been used to monitor the oxidative stress in the stratum
corneum (Thiele et al, 1998). In contrast, in vivo skin
chemiluminescence method can be used to assess the
oxidative stress in both the stratum corneum and the viable
epidermis and dermis (Figs 4 and 5).
The decay of chemiluminescence emission measured on
human skin immediately following UVA exposure has been
previously shown (Sauermann et al, 1999; Rougier and
Richard, 2002). A straightforward method to correlate the
level of oxidative stress in the skin and the chemilumines-
cence signal is to integrate the area under the decay curve
(Figs 4b and 5b). Another approach is to consider the
chemiluminescence signal at the same time point for
different conditions (Evelson et al, 1997). These methods,
however, do not consider the characteristics of the decay
Figure 5
(a) UVA-induced skin chemiluminescence is oxygen dependent. The
initial burst of UVA-induced chemiluminescence (Mean  SD, N¼ 5
subjects) was measured in the absence or presence of a pressure cuff
(set at 30 or 60 mmHg-pressure with UVA dose¼2 J per cm2 and
fluence rate¼15 mW per cm2). p value was calculated from paired t
test. (b) UVA-induced oxidative stress occurs in both the stratum
corneum and the viable skin layers. Tape-stripping was combined with
the application of a pressure cuff to further reduce the UVA-induced
skin chemiluminescence signals. The initial burst of UVA-induced skin
chemiluminescence (mean  SD, N¼5 subjects) was compared for
the various conditions: untreated control, tape-stripped ten times,
tape-stripped ten times plus the application of a pressure cuff (60
mmHg) during the UVA exposure.
Figure6
Topical application of vitamin C can reduce the UVA-induced skin
chemiluminescence. The total counts of the first 50 s of UVA (dose¼
2 J per cm2 and fluence rate¼15 mW per cm2)-induced chemilumi-
nescence signals were averaged (mean  SD, N¼7 subjects) and
compared for skin sites treated with vehicle, 0.1% of vitamin C, and 3%
of vitamin C. p value was calculated from paired t test.
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kinetics (i.e., initial burst and decay constant). A model has
been introduced in this study to facilitate our understanding
of the UVA-induced skin chemiluminescence decay. The
experiment includes two distinct steps:
Exposure : R$ R
Decay : R ! R ðk1Þ;
where k1 represents the rate constant for the decay. If we
assume a steady state during the exposure, i.e., the
chemiluminescence emission reaches equilibrium quickly
at the onset of the exposure and remains constant during
the exposure, the kinetic of the chemiluminescence decay
can be expressed as
½R ¼ ½R0ek1t; ð1Þ
where [R ]0 corresponds to the initial burst (parameter ‘‘A’’)
of the decay and is influenced only by the exposure
condition (i.e., fluence rate) and the recovery capacity of
the skin during the exposure. The rate constant k1
corresponds to the decay constant (parameter ‘‘B’’) and
has been related to UVA dose. Compared with other
methods, this model can be used to differentiate the dose
response and the fluence rate response of the chemilumi-
nescence decay (Figs 2 and 3) and provides an insight into
how the skin antioxidant system may respond to the UVA-
induced oxidative stress.
The proposed model takes into consideration both the
exposure period and the decay period, although no
chemiluminescence measurements could be made during
the exposure period (the UVA source would saturate the
detector). For one given UVA dose, varying the fluence rate
means varying the exposure time. A question then arises as
to how do the exposure conditions (fluence rate and
exposure time) affect the total amount of skin chemilumi-
nescence induced by UVA exposure. In this study, the initial
burst of the decay was found to be related to the fluence
rate; however, the exposure time is also important for
estimating skin chemiluminescence during the exposure if a
steady state is assumed (Fig 7). The total amount of light
emission from the skin induced by UVA should be the sum
of the chemiluminescence during the exposure and the
decay periods. It corresponds to the integrated area under
the curve in Fig 7 and can be expressed as
total chemiluminescence ¼ ðinitial burst
 exposure timeÞ
þ decay integration ð2Þ
The dose and fluence rate response curves of the total UVA-
induced skin chemiluminescence are presented in Figs 8a
and b using Equation (2). Interestingly, the total UVA-
induced chemiluminescence depends strongly on the dose,
but is practically independent of the fluence rate. Thus we
can reduce the analysis to a single parameter model by
considering both the exposure step and the decay step.
Although it has been proposed that singlet oxygen and
excited carbonyls may be involved in the process of photon
emission (Boveris et al, 1980, 1981; Barnard et al, 1993), the
exact origin of the emitted photons still remains unknown. In
fact, information about the spectral distribution of the in vivo
skin chemiluminescence could be very useful in the
characterization of reactive intermediates; however, the
weak photon emission from the skin limits the use of filters
or other light-discriminating devices (Evelson et al, 1997).
An alternative approach to characterize the source of UVA-
induced skin chemiluminescence is to use antioxidants to
quench the signal. An earlier report on UVA-induced in vivo
chemiluminescence in mouse skin has shown that topical
application of a-tocopherol (10% wt/vol in acetone) or
b-carotene (1 mM in acetone) can block the signal (Evelson
et al, 1997). In this study, topical application of vitamin C
(3% wt/vol in a skin-compatible vehicle) to human skin
significantly reduced the UVA-induced chemiluminescence.
Unlike a-tocopherol or b-carotene, vitamin C does not
absorb UVA and its quenching activity arises primarily due
to its capacity to scavenge the reactive species in the skin.
This reduction of the UVA-induced chemiluminescence
emission by an antioxidant further demonstrates that the
UVA-induced chemiluminescence emission is related to
reactive species.
A better understanding of the effects of UVA radiation on
different skin layers may help to design better defense
schemes. This study demonstrated that part of the UVA-
induced chemiluminescence comes from the stratum
corneum, thereby confirming that the outermost layer of
the skin is an important UVA target and thus a source of
oxidative stress. Keratin cross-links, which are present in
corneocytes, may be the primary absorbers of UVA in the
Figure7
Proposed model for UVA-induced chemiluminescence of skin. The
total UVA-induced skin chemiluminescence (including both the decay
period and the exposure period) can be characterized by the integrated
area under the chemiluminescence curve. (a) FR1 and FR2 represent
two experiments with the same UVA dose, but different fluence rates
(FR1oFR2). The dotted line separates the exposure period from the
decay period. (b) D1 and D2 represent two experiments with the same
fluence rate but different UV doses (D1oD2). The dotted line separates
the exposure period from the decay period.
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stratum corneum. Oxidative stress in the stratum corneum
could be a mechanism for the UVA-induced changes of
stratum corneum barrier function described by McAuliffe
and Blank (1991).
UVA-induced oxidative stress involves more than the
superficial layer of the skin. The correlation between
chemiluminescence signals and blood oxygen supply
reveals that some of the signals may originate from the
viable layers of the skin. Oxygen can be supplied to the skin
tissue either by the atmosphere or by the blood vessels. A
30%–40% reduction of the initial burst was observed when
a pressure cuff on the upper arm was inflated to a pressure
of 60 mmHg, strongly suggesting that at least this portion of
the chemiluminescence signal came from the vascularized
dermis and the viable epidermis. This is possible because
chemiluminescence emission is believed to occur at
wavelengths longer than the hemoglobin absorption bands
at 540–590 nm; therefore the attenuation of chemilumines-
cence by blood vessels is not significant. Interestingly, the
combination of tape-stripping and application of a pressure
cuff further reduced the chemiluminescence signal (Fig 5b),
indicating that the origins of the chemiluminescence that
can be modulated by tape-stripping and by application of a
pressure cuff are additive and therefore to a great degree
independent. In fact, UVA photons penetrate into the dermis
and induce structural changes in collagen. In vivo fluores-
cence spectroscopy has revealed that the intensity of the
intrinsic collagen cross-link fluorescence decreases follow-
ing UVA exposure (Kollias et al, 1998; Tian et al, 2001) at
doses similar to the ones used in this study, suggesting that
photochemical reactions may occur readily in the dermis.
Dermal collagen cross-links are possible targets for UVA
photons and their break-down may contribute to the overall
chemiluminescence signal.
In this study, we used chemiluminescence emission to
assess the UVA-induced oxidative stress in human skin
in vivo. We established the dependence of chemilumines-
cence signal on the UVA dose and fluence rate. The model
proposed, considering the chemiluminescence emission
during both the exposure and the decay times, allows the
estimation of the total UVA-induced skin chemilumines-
cence emission. We demonstrated that the oxidative
interaction between UVA photons and the skin is partially
oxygen-dependent and may be reduced by topical applica-
tion of antioxidants. This interaction occurs both in the
stratum corneum and the deeper layers. Moreover, this
study highlights the advantages of chemiluminescence as a
non-invasive method to study in vivo cutaneous oxidative
stress in human skin. The presented method can be easily
adapted to measure the protective properties of antiox-
idants against photo- and chemical-induced oxidative
stress in human skin.
Materials and Methods
Chemicals Hydrogen peroxide (H2O2), sodium hypochlorite
(NaOCl) and L-ascorbic acid (vitamin C) were purchased from
Sigma Chemicals (St. Louis, Missouri). H2O2 and NaOCl were
diluted in water/propylene glycol (70:30, vol/vol). Ascorbic acid
was dissolved in water/ethanol/propylene glycol (50:35:15, vol/vol).
Instrumentation
UVA light source The UVA light source used throughout this study
was a Hamamatsu LightingCure 200 UV Spot light source
(Hamamatsu, Bridgewater, New Jersey) with a 150 W Xenon lamp
and a UV dichroic reflector fixed behind the lamp to direct and filter
the light (filter range from 300 to 450 nm with maximum at 365 nm).
The light source was further filtered with Schott UG11 (1 mm) and
WG335 (3 mm) glass filters (Schott, Elmsford, New York). The
output was delivered to a beam conditioner (Hamamatsu E5147–
06) by a quartz fiber bundle (Hamamatsu A2873, 10 mm in
diameter). Condenser lenses were used to provide large areas of
uniform irradiation (up to 100  100 mm). The spot size of UVA
illumination on the skin was adjusted to be 2.5 cm in diameter so
Figure 8
Integrating the chemiluminescence signal over the times during and following UVA exposure results in a single parameter model (i.e.,
removes the fluence rate dependency). (a) UVA dose response (fluence rate¼ 20 mW per cm2) of estimated total chemiluminescence signals. The
dose response curve presents a stronger linear correlation compared with Fig 2b (b) UVA fluence rate response (dose¼ 2 J per cm2) of estimated
total chemiluminescence signals. The fluence rate response curve is practically independent of the fluence rate.
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that it matched the size of the photomultiplier import port. The
spectral distribution of this source (Fig 9) was characterized with a
spectroradiometer (Optronic Laboratories, Orlando, Florida, model
752). The spectral output of the source was in the UVA range with
maximum output in 340–380 nm and less than 0.5% of the
maximum irradiance at wavelengths below 320 nm. The output of
this light source was routinely monitored with a thermopile (Oriel,
Stratford, Connecticut, Model 71140), which was calibrated by
Eppley Laboratory (New Port, Rhode Island).
Chemiluminescence setup (Fig 10) Photons emitted from the skin
were measured by a red-sensitive, tri-alkali photomultiplier (PMT)
with a 2.5 cm diameter photocathode surface (Electron Tubes,
Rockaway, New Jersey, Model 9828SA). The photomultiplier was
in a Peltier-cooled housing unit (Electron Tubes, Model CDM30)
and was routinely cooled to 181C–201C to reduce detector noise.
The housing unit can be held with one hand as a probe and placed
on the skin area to be measured. The surface of the photocathode
was only protected by a manual shutter (Products for Research,
Inc. Danvers, Massachusetts, Model PR318). The shutter is
opened for measurements and closed for instrument background.
The distance between the skin and the photocathode surface was
about 1.5 cm. The PMT was supplied with a potential of 1.15 kV
of high voltage (Brandenburg, Brierley Hill, UK, Model 477) with a
variation less than  2 V. After going through an amplifier and
discriminator (Electronic Tubes, Model AD6), the output signals
from the PMT were measured in a photon-counting module
(Electronic Tubes, Model CT1) and recorded by a computer. All
measurements were conducted in a positively dark room, other-
wise the background would overwhelm the signal. Volar forearms
were used for all the in vivo measurements.
Measurements
General procedure An independent review board approved the
study. Nine human volunteers of Fitzpatrick skin type II-IV
participated in the study and they gave written consent prior to
the experiments. Baseline chemiluminescence measurements
were acquired from a skin site on the volar forearm before the
site was exposed to UVA irradiation. Immediately following UVA,
the same skin site was presented to the detector to collect the
UVA-induced chemiluminescence. Data were collected over 5 min
following each UVA exposure to monitor the skin recovery process.
In the experiments involving H2O2 and NaOCl, the solutions were
applied on a skin area of 2.5 cm in diameter (to match the detector
size) using a pipette. Typically, the final concentrations of 12–120
mg per cm2 of H2O2 and 0.01–0.1 mg per cm
2 of NaOCl solutions
were applied topically on the skin. The subsequent measurements
were conducted within 3–5 min following the application of H2O2
and NaOCl. In the vitamin C experiments, 20 mL of the vehicle,
0.1%, and 3% vitamin C (wt/vol) solutions were applied on three
different but adjacent skin sites (2.5 cm in diameter) of each
subject. These sites were exposed to UVA 4 h later and the
chemiluminescence measurements were subsequently taken.
Dose response A series of UVA doses (ranging from 0.2 to 10 J per
cm2) were delivered to the volar forearm of each subject with a
constant fluence rate of 20 mW per cm2. No erythema was
detected for any subject either immediately or 24 h after the
exposure. For some people, immediate pigment darkening was
observed at doses greater than 2 J per cm2 but faded away in a
few minutes.
Fluence rate response A series of exposures of the same UVA
dose (2 J per cm2) and different fluence rates (ranging from 2 to 20
mW per cm2) were applied on the volar forearm of each subject,
and chemiluminescence measurements were conducted before
and immediately after UVA exposure.
Tape-stripping Adhesive D-squame tapes (2.5 cm in diameter,
Cuderm Corporation, Dallas, Texas) were applied on the skin of five
subjects and gently removed after one minute of application. The
procedure was repeated ten times for each subject. The tape-
stripped site was subsequently exposed to UVA (dose¼ 2 J per
cm2 and fluence rate¼ 15 mW per cm2), and chemiluminescence
was recorded for the same skin site. The thickness of the stratum
corneum was measured before and after 10 tapes by an in vivo
confocal microscope (Lucid, Henrietta, New York, Vivascope
1000). The detailed operating procedure of confocal microscope
has been described elsewhere (Rajadhyaksha et al, 1999).
Oxygen dependency Oxygen supply to the skin can be modulated
by arterial occlusion and this can be accomplished by applying a
subdiastolic pressure. A pressure cuff was applied on the upper
arms of each of the five subjects during UVA exposure (dose¼ 2 J
per cm2 and fluence rate¼ 15 mW per cm2). For each subject,
three different pressures settings (0, 30, and 60 mmHg) were used
to regulate the blood oxygen supply to the skin on the lower
forearm (measurement site). In each experiment, the pressure was
kept in place 5 min before and during the exposure. The pressure
was released immediately after the exposure to eliminate any
possible attenuation of the signals from concentration variations of
Figure 9
UVA light source. The spectral distribution of the light source used in
this study.
Figure 10
Chemiluminescence measurement setup. PMT refers to the photo-
multiplier.
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deoxy-hemoglobin in skin tissues. The chemiluminescence mea-
surement started after the release of the pressure and continued
for 5 min.
In another set of experiments, a skin site on the volar forearm of
each of the five subjects was tape-stripped ten times before a
pressure cuff was applied. Then the same procedure was followed
to examine the combination effect of tape-stripping and applied
pressure.
Data analysis The chemiluminescence signals collected following
UVA exposure were first corrected by the baseline spontaneous
chemiluminescence signal and then integrated over the decay
time. The UVA-induced chemiluminescence decay curves were
also fitted to a two-parameter exponential function y¼A  e-Bt
after the baseline correction, where ‘‘t’’ represents the time
immediately following the UVA exposure. Parameter ‘‘B’’ repre-
sents the decay constant of the curve and parameter ‘‘A’’
represents the initial burst of the signal. The data were expressed
as mean  SD for five to nine subjects. Paired t tests were
conducted to compare the mean values of different data sets.
DOI: 10.1111/j.0022-202X.2004.22405.x
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